Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Biomater Appl ; 31(3): 357-65, 2016 09.
Article in English | MEDLINE | ID: mdl-27511982

ABSTRACT

The aim of this study was to characterise the elution profiles of antibiotics in combination with pharmaceutical grade calcium sulphate beads in phosphate buffered saline and other physiological solutions which more closely mimic the in vivo environment. Synthetic recrystallised calcium sulphate was combined with vancomycin hydrochloride powder and tobramycin sulphate solution and the paste was formed into 3 mm diameter hemispherical beads. Then 2 g of beads were immersed in 2 ml of either phosphate buffered saline, Dulbecco's Modified Eagle Medium or Hartmann's solution and incubated at 37℃ for up to 21 days. At a range of time points, eluent was removed for analysis by liquid chromatography-mass spectrometry (LC-MS). Tobramycin sulphate and vancomycin hydrochloride release was successfully quantified against standard curves from solutions eluted in all three physiological media (phosphate buffered saline, Dulbecco's Modified Eagle Medium and Hartmann's solution) during incubation with calcium sulphate beads. One hour eluate concentrations were high, up to 2602 µg/ml for tobramycin in phosphate buffered saline and 7417 µg/ml for vancomycin, whereas in DMEM, the levels of tobramycin were 2458 µg/ml and 4401 µg/ml for vancomycin. The levels in HRT were 2354 µg/ml for tobramycin and 5948 µg/ml for vancomycin. The results show highest levels of antibiotic elution over the first 24 h, which gradually diminish over the following 21 days.


Subject(s)
Body Fluids/chemistry , Calcium Sulfate/chemistry , Drug Implants/chemistry , Tobramycin/chemistry , Vancomycin/chemistry , Anti-Infective Agents/administration & dosage , Anti-Infective Agents/chemistry , Biomimetic Materials/chemistry , Diffusion , Drug Implants/administration & dosage , Humans , Kinetics , Tobramycin/administration & dosage , Vancomycin/administration & dosage
2.
J Exp Bot ; 66(9): 2547-56, 2015 May.
Article in English | MEDLINE | ID: mdl-25711707

ABSTRACT

Studying the biochemical responses of different plant species to insect herbivory may help improve our understanding of the evolution of defensive metabolites found in host plants and their role in plant-herbivore interactions. Untargeted metabolic fingerprints measured as individual mass features were used to compare metabolite reactions in three Brassicales host-plant species (Cleome spinosa, Brassica oleracea, and Lunaria annua) to larval herbivore attack (Pieris rapae; Lepidoptera). Principal component analyses of metabolic fingerprints were able to distinguish among the three plant species and between uneaten control plants and plants that had been eaten. A large number of mass features (1186, 13% of mass features measured in control plants) were common to the three plant species. However, there were few similarities in the mass features that were induced (i.e. changed in abundance) following herbivory. Of the 87 and 68 induced mass features in B. oleracea and C. spinosa, respectively, there were only three that were induced in both plant species. By contrast, L. annua only had one mass feature induced by herbivory, and this was not induced in the other two plant species. The growth of the P. rapae larvae was poorer on the host plant L. annua than on B. oleracea and C. spinosa. The absence of common metabolites among the plants meant these induced responses could not be related to the performance of the herbivore. Thus, the response to herbivory by the same herbivore in these three host plants has evolved to be idiosyncratic in terms of the specific metabolites induced.


Subject(s)
Brassicaceae/metabolism , Butterflies/physiology , Herbivory , Animals , Brassicaceae/classification , Brassicaceae/physiology , Glucosinolates/metabolism , Larva/physiology , Metabolism , Phylogeny , Plant Leaves/metabolism , Plant Leaves/physiology
3.
J Physiol ; 537(Pt 1): 57-68, 2001 Nov 15.
Article in English | MEDLINE | ID: mdl-11711561

ABSTRACT

1. Large-conductance Ca(2+)- and voltage-activated potassium (BK) channels are important regulators of cellular excitability. Here, we present a patch-clamp electrophysiological analysis of splice-variant-specific regulation by the synthetic glucocorticoid dexamethasone (DEX) of BK channels consisting of cloned STREX or ZERO alpha-subunit variants expressed in human embryonic kidney (HEK 293) cells. 2. STREX channels in isolated membrane patches were inhibited by protein kinase A (PKA) and this was blocked on pre-treatment of intact cells with DEX (100 nM) for 2 h. 3. The effect of DEX required the synthesis of new mRNA and protein. Furthermore, it required protein phosphatase 2A (PP2A)-like activity intimately associated with the channels, as it was blocked by 10 nM okadaic acid but not by the specific protein phosphatase-1 inhibitor peptide PPI-2. 4. ZERO variant channels that lack the STREX insert were activated by PKA but were not influenced by DEX. ZERO channels containing a mutant STREX domain (S4(STREX)A) were also activated by PKA. Importantly, DEX blocked PKA activation of S4(STREX)A channels in a PP2A-dependent manner. 5. Taken together, the STREX domain is crucial for glucocorticoid regulation of BK channels through a PP2A-type enzyme. Moreover, glucocorticoids appear to induce a generic set of proteins in different types of cells, the actions of which depend on the expression of cell-specific targets.


Subject(s)
Alternative Splicing , Dexamethasone/pharmacology , Glucocorticoids/pharmacology , Potassium Channels, Calcium-Activated/drug effects , Potassium Channels, Calcium-Activated/genetics , Animals , Cell Line , Cyclic AMP-Dependent Protein Kinases/physiology , Humans , Large-Conductance Calcium-Activated Potassium Channel alpha Subunits , Large-Conductance Calcium-Activated Potassium Channels , Mice , Phosphoprotein Phosphatases/physiology , Potassium Channel Blockers , Potassium Channels/chemistry , Potassium Channels/drug effects , Potassium Channels/metabolism , Protein Biosynthesis , Protein Isoforms/metabolism , Protein Phosphatase 1 , Protein Phosphatase 2 , Protein Structure, Tertiary/physiology , RNA, Messenger/biosynthesis , Receptors, Glucocorticoid/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...